GlassScriptPhysician profile
Garth B Tanner
NPI 1184612624
$7,757.21
in general payments reported to CMS, 2019-2025
43 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $442 · 2021: $1,045 · 2022: $1,197 · 2023: $1,460 · 2024: $1,917 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,528.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,967.00 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $661.99 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $593.28 | 2019-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $476.18 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Sumitomo Pharma America, INC. | $459.13 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $300.15 | 2021-2025 | |
| Corcept Therapeutics | $276.62 | 2024-2025 | Korlym |
| Exact Sciences Corporation | $224.90 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $198.04 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $186.68 | 2020-2021 | |
| Pfizer INC. | $184.72 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $167.56 | 2022 | |
| Novartis Pharmaceuticals Corporation | $163.96 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $150.57 | 2022-2024 | Hetlioz |
| Merck Sharp & Dohme LLC | $145.57 | 2020-2024 | Dificid, Capvaxive, Gardasil 9 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garth Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.